Health / Fri, 10 Jul 2026 News18

Cure For Fatty Liver? Scientists Reveal Game-Changing Drug That Heals From The Inside

Last Updated: July 10, 2026, 14:38 IST1 / 5 Fatty liver disease, particularly severe MASH, silently affects millions worldwide, driving rising cases of cirrhosis, cancer, and failure amid obesity epidemics. A new drug candidate DT-109 now offers hope by treating it through gut health restoration in preclinical models. It reduces harmful Clostridium perfringens bacteria and ammonia production, preventing toxin leakage that fuels liver inflammation. 4 / 5 How Does Gut Health Influence Fatty Liver Disease? Disrupted gut microbiota plays a central role in fatty liver progression.

Last Updated: July 10, 2026, 14:38 IST

1 / 5 Fatty liver disease, particularly severe MASH, silently affects millions worldwide, driving rising cases of cirrhosis, cancer, and failure amid obesity epidemics. A new drug candidate DT-109 now offers hope by treating it through gut health restoration in preclinical models.

2 / 5 Researchers at Michigan Medicine – University of Michigan developed this glycine-based tripeptide that targets the gut-liver axis. It reduces harmful Clostridium perfringens bacteria and ammonia production, preventing toxin leakage that fuels liver inflammation. Published in The Journal of Clinical Investigation (2026), the study reveals how DT-109 reverses MASH pathology, addressing a condition with few effective therapies despite its global burden.

3 / 5 What Is MASH?

MASH impacts about 7% of the global population, fueled by modern lifestyles involving poor diet and inactivity. It progresses from simple fat accumulation to inflammation and scarring, often without early symptoms. Left unchecked, it leads to end-stage liver disease requiring transplants. The rising prevalence strains healthcare systems everywhere, making accessible treatments like DT-109 critically important.

4 / 5 How Does Gut Health Influence Fatty Liver Disease?

Disrupted gut microbiota plays a central role in fatty liver progression. Ammonia-producing bacteria weaken the intestinal lining, enabling harmful substances to reach the liver and provoke damaging immune responses. DT-109 counters this by modulating bacteria levels and restoring barrier function, highlighting why gut-focused strategies are key to managing metabolic liver conditions worldwide.